鼎豐集團控股(06878.HK)獲行政總裁兼執行董事吳志忠增持1200萬股
格隆匯 4 月 19日丨鼎豐集團控股(06878.HK)發佈公吿,公司獲行政總裁兼執行董事吳志忠先生吿知,2021年4月19日,吳先生透過聯交所交易系統購買1200萬股公司股份。
購買股份後,吳先生及其全資擁有的Ever Ultimate Limited於合共1,156,068,000股股份(相當於截至本公吿日期公司已發行股本約16.03%)中擁有權益。此外,吳先生根據公司採納的購股權計劃持有6,400,000份公司購股權。
吳先生已向董事會表示,其滿意公司目前的經營狀況,並對公司前景充滿信心。吳先生亦已表示,在適當情況下,其有意繼續增加於公司的持股量。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.